Ischaemic heart disease

Study reveals why one in three ACS patients stop secondary prevention therapies

Failure to discharge patients on appropriate secondary prevention pharmacotherapies following an acute coronary syndrome is the key factor in why 32% of patients are non-adherent at six-months, figures from an Australian database suggest. A study of 6,595 patients from the CONCORDANCE (Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events) registry found ...

Already a member?

Login to keep reading.

© 2021 the limbic